SCI 발표논문

SCI 발표논문

← SCI 발표논문 목록

Yonsei Med J. 2021;62(1):21-28.

Effectiveness of 4-Week Oral Taurine Treatment for Muscle Cramps in Patients with Liver Cirrhosis: A Single-Arm Pilot Study.

, , ,

제1저자 장은선 · 교신저자 정숙향

소속 (3)
  1. Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
  2. Department of Nursing, Suwon Science College, Hwaseong, Korea.
  3. Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea. jsh@snubh.org.

Abstract

PURPOSE Painful muscle cramps are a common complication in liver cirrhosis patients, and no effective treatment is available. This pilot study aimed to evaluate whether taurine supplementation improves muscle cramps in Korean cirrhotic patients.

MATERIALS AND METHODS Ten cirrhotic patients who experienced muscle cramps one or more times/week were enrolled in this prospective single-arm study and administered with an oral taurine solution (1 g/50 mL) thrice a day for 4 weeks. Taurine was discontinued for the subsequent 4 weeks. The frequency and intensity of muscle cramps were evaluated using a questionnaire at weeks 0, 2, 4, 6, and 8 after the start of treatment.

RESULTS At baseline, the median frequency of muscle cramps was six times/week, and all patients had severe pain. Muscle cramp scores (frequency×intensity) decreased in seven patients by weeks 4 and 8 after treatment initiation. Compared to baseline muscle cramp scores [median 21, interquartile range (IQR): 8-84], median muscle cramp scores were lower at week 4 (6.5, IQR: 3-12, p=0.126) and week 8 (5, IQR: 1.5-56, p=0.066). All five patients whose baseline plasma taurine levels were below the normal limit showed increased taurine levels at week 4; 60% of them experienced improvements in their muscle cramps. Of the five patients with normal or higher taurine levels, 80% experienced an improvement in symptoms at week 4. The safety and tolerability of the 4-week taurine therapy were excellent.

CONCLUSION Oral taurine therapy for 4 weeks improved muscle cramps safely in cirrhotic patients.

© Copyright: Yonsei University College of Medicine 2021.

Keywords

Liver cirrhosismuscle cramptaurine

Figures

Fig. 1
Fig. 1 Changes in the frequency of muscle cramps (A), intensity of muscle cramps (B), and muscle cramp scores (C, overall; D, individually) in Korean liver cirrhosis patients before and after taurine replacement.
Fig. 2
Fig. 2 Change in muscle cramp scores (A and B) and plasma taurine levels (C and D) according to baseline taurine levels in Korean liver cirrhosis patients before and after taurine replacement.
Fig. 3
Fig. 3 Associations among plasma taurine (A), serum magnesium (B), and serum zinc (C) levels, and muscle cramp scores in liver cirrhosis patients.

그림 출처: PubMed Central 공개 논문 (PMC7820453)

Conflict of interest statement

The authors have no potential conflicts of interest to disclose.

그 밖의 정보
출판 형태
Clinical Trial, Journal Article
저널
Yonsei medical journal · eISSN 1976-2437
MeSH
Administration, Oral · Adult · Female · Humans · Liver Cirrhosis / complications · Male · Middle Aged · Muscle Cramp / blood / complications / drug therapy · Pilot Projects · Prospective Studies · Taurine / administration & dosage / blood / therapeutic use · Treatment Outcome
Substances
Taurine
연구비
Dong-A Pharmaceutical
참고문헌
29편